APA

Wolff R. A., Fuchs M., Di Bartolomeo M., Hossain A. M., Stoffregen C., Nicol S. & Heinemann V. (20121024). A double-blind, randomized, placebo-controlled, phase 2 study of maintenance enzastaurin with 5-fluorouracil/leucovorin plus bevacizumab after first-line therapy for metastatic colorectal cancer. : Cancer.

Chicago

Wolff Robert A, Fuchs Martin, Di Bartolomeo Maria, Hossain Anwar M, Stoffregen Clemens, Nicol Steven and Heinemann Volker. 20121024. A double-blind, randomized, placebo-controlled, phase 2 study of maintenance enzastaurin with 5-fluorouracil/leucovorin plus bevacizumab after first-line therapy for metastatic colorectal cancer. : Cancer.

Harvard

Wolff R. A., Fuchs M., Di Bartolomeo M., Hossain A. M., Stoffregen C., Nicol S. and Heinemann V. (20121024). A double-blind, randomized, placebo-controlled, phase 2 study of maintenance enzastaurin with 5-fluorouracil/leucovorin plus bevacizumab after first-line therapy for metastatic colorectal cancer. : Cancer.

MLA

Wolff Robert A, Fuchs Martin, Di Bartolomeo Maria, Hossain Anwar M, Stoffregen Clemens, Nicol Steven and Heinemann Volker. A double-blind, randomized, placebo-controlled, phase 2 study of maintenance enzastaurin with 5-fluorouracil/leucovorin plus bevacizumab after first-line therapy for metastatic colorectal cancer. : Cancer. 20121024.